Screener
AbCellera Biologics Inc. ABCL Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $4.05M-76.3% | $8.32M+96.3% | $44.85M+788% | $8.96M+37.6% | $17.08M+133% | ||
| $45.99M+17.3% | $46.66M+9.8% | $50.09M+8.7% | $55.03M+34.3% | $39.21M-4.2% | ||
| $13.85M-37.0% | $12.33M-35.3% | —— | —— | $21.99M— | ||
| $66.83M+0.2% | $65.83M-1.6% | $73.44M-5.6% | $85.23M-14.9% | $66.67M-33.8% | ||
| -$62.78M-26.6% | -$57.52M+8.2% | -$28.58M+60.7% | -$76.28M+18.6% | -$49.59M+46.9% | ||
| -1,550%-1,260pp | -691.7%+788pp | -63.7%+1,377pp | -851.8%+588pp | -290.2%+986pp | ||
| -$42K-100% | —— | —— | —— | $9.55M— | ||
| $3.81M-71.2% | $7.98M-17.5% | $9.08M-65.0% | $7.51M-75.8% | $13.24M-70.7% | ||
| -$58.97M-62.2% | -$49.54M+6.5% | -$19.5M+58.4% | -$68.77M-9.8% | -$36.34M+24.6% | ||
| -$3.54M-119% | -$6.37M+13.5% | -$10.55M+16.4% | -$11.65M-1.1% | -$1.62M+85.6% | ||
| -$55.43M-59.6% | -$43.17M+5.4% | -$8.95M+73.9% | -$57.12M-11.8% | -$34.73M+6.0% | ||
| -1,368.6%-1,165pp | -519.1%+558pp | -19.9%+657pp | -637.8%+148pp | -203.3%+301pp | ||
| -$0.18-50.0% | -$0.14+6.7% | -$0.03+72.7% | -$0.19-11.8% | -$0.12+7.7% | ||
| -$55.79M-26.5% | -$50.68M+11.6% | -$22.49M+68.2% | -$71.03M-25.2% | -$44.12M+22.5% | ||
| -1,377.5%-1,119pp | -609.5%+744pp | -50.1%+1,349pp | -793.2%+78.8pp | -258.2%+519pp | ||
| -$62.78M-26.6% | -$57.52M+8.2% | -$28.58M+60.7% | -$76.28M+18.6% | -$49.59M+46.9% |
FAQ
- What is AbCellera Biologics Inc.'s revenue?
- AbCellera Biologics Inc. (ABCL) generated $66.2M in revenue over the trailing twelve months, up 101.3% year over year.
- Is AbCellera Biologics Inc. profitable?
- AbCellera Biologics Inc. is not currently profitable: it reported a net loss of $164.7M over the trailing twelve months, a -248.8% net margin.
- What is AbCellera Biologics Inc.'s earnings per share?
- AbCellera Biologics Inc.'s diluted EPS over the trailing twelve months is $-0.54.
- Where does AbCellera Biologics Inc.'s income statement data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
